Traveling young injection drug users at high risk for acquisition and transmission of viral infections

Drug and Alcohol Dependence

Volumn 93, Issue 1-2, 2008, Pages 43-50

  Hahn, Judith A ^a   Page Shafer, Kimberly ^a   Ford, Jamye ^a   Paciorek, Alan ^a   Lum, Paula J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hepatitis B virus; Hepatitis C virus; Injection drug use; Mobility; Vaccination

Indexed keywords

COCAINE; METHAMPHETAMINE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE TRANSMISSION; DRUG USE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NEEDLE; PRIORITY JOURNAL; RISK FACTOR; SEMI STRUCTURED INTERVIEW; SEXUAL BEHAVIOR; SUBSTANCE ABUSE; TRAVEL; VIRUS INFECTION; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGE FACTORS; ANTIBODIES, VIRAL; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; IMMUNIZATION SCHEDULE; INCIDENCE; MALE; MASS SCREENING; NEEDLE SHARING; PREVALENCE; RISK FACTORS; RISK-TAKING; SEXUAL PARTNERS; SUBSTANCE ABUSE, INTRAVENOUS; TRAVEL; VACCINATION; VIRAL HEPATITIS VACCINES;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 36849046662     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2007.08.016     Document Type: Article

References (30)

1. Becker Buxton M., Vlahov D., Strathdee S.A., Des Jarlais D.C., Morse E.V., Ouellet L., Kerndt P., and Garfein R.S. Association between injection practices and duration of injection among recently initiated injection drug users. Drug Alcohol Depend. 75 (2004) 177-183
2. Booth R., Watters J., and Chitwood D. HIV risk-related sex behaviors among injection drug users, crack smokers, and injection drug users who smoke crack. Am. J. Public Health 83 (1993) 1144-1148
3. Burt R.D., Hagan H., Garfein R.S., Sabin K., Weinbaum C., and Thiede H. Trends in Hepatitis B Virus, Hepatitis C Virus, and Human Immunodeficiency Virus Prevalence, Risk Behaviors, and Preventive Measures among Seattle Injection Drug Users Aged 18-30 Years, 1994-2004. J. Urban Health 84 (2007) 436-454
4. Costenbader E.C., Astone N.M., and Latkin C.A. The dynamics of injection drug users' personal networks and HIV risk behaviors. Addiction 101 (2006) 1003-1013
5. Des Jarlais D.C., Perlis T., Arasteh K., Torian L.V., Hagan H., Beatrice S., Smith L., Wethers J., Milliken J., Mildvan D., Yancovitz S., and Friedman S.R. Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001. AIDS 19 Suppl. 3 (2005) S20-S25
6. Des Jarlais D.C., Perlis T., Torrico C., and Settembrino J.M. Travel patterns among young Urban Nomad injecting drug users (IDUs) in the United States. The 130th Annual Meeting of the APHA. Philadelphia, PA (2002)
7. Des Jarlais D.C., Perlis T.E., and Settembrino J.M. The use of electronic debit cards in longitudinal data collection with geographically mobile drug users. Drug Alcohol Depend. 77 (2005) 1-5
8. Fenaughty A.M., and Fisher D.G. High-risk sexual behavior among drug users. The utility of a typology of alcohol variables. Sex Transm. Dis. 25 (1998) 38-43
9. Garfein R.S., Doherty M.C., Monterroso E.R., Thomas D.L., Nelson K.E., and Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 18 Suppl. 1 (1998) S11-S19
10. Garfein R.S., Lakta M., Hagan H., Ouellet L., Hudson S.M., Strathdee S.A., Purcell D., Thiede H., Golub E.T., Bailey S., Kerndt P., Kapadia F., and Hanson D. The Collaborative Injection Drug Users Study III/Drug Users Intervention Trial (DUIT) (2005), American Public Health Association, Philadelphia
11. German D., Davey M.A., and Latkin C.A. Residential Transience and HIV Risk Behaviors Among Injection Drug Users. AIDS Behav. (2007)
12. Hahn J.A., Page-Shafer K., Lum P.J., Bourgois P., Stein E., Evans J.L., Busch M.P., Tobler L.H., Phelps B., and Moss A.R. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J. Infect. Dis. 186 (2002) 1558-1564
13. Hahn J.A., Page-Shafer K., Lum P.J., Ochoa K., and Moss A.R. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology 34 (2001) 180-187
14. Kapadia F., Latka M.H., Hagan H., Golub E.T., Campbell J.V., Coady M.H., Garfein R.S., Thomas D.L., Bonner S., Thiel T., and Strathdee S.A. Design and Feasibility of a Randomized Behavioral Intervention to Reduce Distributive Injection Risk and Improve Health-Care Access Among hepatitisC virus Positive Injection Drug Users: The Study to Reduce Intravenous Exposures (STRIVE). J. Urban Health 84 (2007) 99-115
15. Kral A.H., Lorvick J., and Edlin B.R. Sex- and drug-related risk among populations of younger and older injection drug users in adjacent neighborhoods in San Francisco. J. Acquir. Immune Defic. Syndr. 24 (2000) 162-167
16. Liaw Y.F., and Sollano J.D. Factors influencing liver disease progression in chronic hepatitis B. Liver Int. 26 Suppl. 2 (2006) 23-29
17. Lum P.J., Ochoa K.C., Hahn J.A., Page Shafer K., Evans J.L., and Moss A.R. Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: the UFO Study. Am. J. Public Health 93 (2003) 919-923
18. McCoy C.B., Metsch L.R., Chitwood D.D., and Miles C. Drug use and barriers to use of health care services. Subst. Use Misuse 36 (2001) 789-806
19. NIAAA, 2004. NIAAA Council Approves Definition of Binge Drinking. NIAAA Newletter (3).
20. Parker R.G., Easton D., and Klein C.H. Structural barriers and facilitators in HIV prevention: a review of international research. AIDS 14 Suppl. 1 (2000) S22-S32
21. Perrin L., Kaiser L., and Yerly S. Travel and the spread of HIV-1 genetic variants. Lancet Infect. Dis. 3 (2003) 22-27
22. Pessione F., Degos F., Marcellin P., Duchatelle V., Njapoum C., Martinot-Peignoux M., Degott C., Valla D., Erlinger S., and Rueff B. Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C. Hepatology 27 (1998) 1717-1722
23. Peters M.G., and Terrault N.A. Alcohol use and hepatitis C. Hepatology 36 (2002) S220-S225
24. Rachlis B., Brouwer K.C., Mills E.J., Hayes M., Kerr T., and Hogg R.S. Migration and transmission of blood-borne infections among injection drug users: understanding the epidemiologic bridge. Drug Alcohol Depend. 90 (2007) 107-119
25. Sanders, B., Lankenau, S.E., Jackson Bloom, J., Hathazi, D. Multiple drug use and polydrug use amongst homeless traveling youth. J. Ethnicity Subst. Abuse, in press.
26. Schiff E.R., and Ozden N. Hepatitis C and alcohol. Alcohol Res. Health 27 (2003) 232-239
27. Shafer K.P., Hahn J.A., Lum P.J., Ochoa K., Graves A., and Moss A. Prevalence and correlates of HIV infection among young injection drug users in San Francisco. J. Acquir. Immune Defic. Syndr. 31 (2002) 422-431
28. Siegal H.A., Carlson R.G., Falck R., Li L., Forney M.A., Rapp R.C., Baumgartner K., Myers W., and Nelson M. HIV infection and risk behaviors among intravenous drug users in low seroprevalence areas in the Midwest. Am. J. Public Health 81 (1991) 1642-1644
29. Thorpe L., Ouellet L., Levy J., Williams I., and Monterroso E. Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997-1999. J. Infect. Dis. 182 (2000) 1588-1594
30. Williams M.L., Zhao Z., Bowen A.M., Freeman R.C., Elwood W.N., and Rusek R. Introduction of HIV into drug injector networks outside AIDS epicentres. Int. J. STD AIDS 8 (1997) 629-635